written on 09.06.2014

As Algeta's sibling, can Nordic Nanovector find the same success?


He said: "Not only does Betalutin target a novel therapeutic target (CD37 instead of CD20), the radioisotope Lu-177 is novel and has favorable properties in comparison to other radioisotopes such as I and Yt which were used in first generation…